Prediction: This Will Be Eli Lilly's Next Billion-Dollar Growth Driver. (Hint: It's Not Weight Loss Drugs.

Eli Lilly has captured investor attention with its blockbuster weight-loss drugs and now dominates the U.S. market for these treatments. Market leadership in a high-demand category supports upside to revenue growth and could drive further stock outperformance.

Analysis

Eli Lilly has captured investor attention with its blockbuster weight-loss drugs and now dominates the U.S. market for these treatments. Market leadership in a high-demand category supports upside to revenue growth and could drive further stock outperformance.